Apotex Corp. announced on May 14, 2018 that it is voluntarily recalling 36 lots of Piperacillin and Tazobactam for injection, USP 3.375 gram/vial and 4.5 gram/vial strengths to the consumer level. The product is manufactured by Hospira, Inc., a Pfizer Company, and distributed by Apotex. TheOriginal Article
You may also like
Pharmaceutical Sales Customer Engagement –...
AstraZeneca’s Polyneuropathy Treatment Recommended...
Designing a Strategic Roadmap for Seamless Product...
AAPS PharmSci 360: LBFs and Tackling Oral Biologic...
CHMP Gives Positive Opinion to Novo Nordisk Hemophilia...
GSK, Cambridge to Partner on R&D for Kidney and...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.